Regulatory-informed
AI Workflows
for Pharmaceutical
Compliance
Supporting ABPI Code-aligned review, reference checking, and citation verification across the UK and EU.
Pharmaceutical compliance requires precision, judgement, and consistency —especially as AI enters regulated environments.
Our platform unites expert-built compliance workflows with rigorously developed AI to create processes that are robust, auditable, and aligned with real regulatory standards.
Developed by senior regulatory professionals and experienced AI data scientists, the system reflects both how compliance is assessed in practice and how AI can be applied responsibly within pharmaceutical governance frameworks.
Dr Anzal Qurbain
Founder & CEO
Dr Anzal Qurbain is a GMC-registered pharmaceutical physician and Final ABPI Signatory, with 25+ years' experience leading medical affairs, compliance, safety and governance across both global and local organisations.
He's made and defended thousands of real-world approval decisions—from claim substantiation and fair balance to complex digital and omnichannel materials—bringing a rare blend of regulatory rigour and practical execution.
As Founder & CEO of Daai Systems, Anzal applies the same standard to AI: tools must be evidence-anchored, explainable, auditable, and accountable by design. He backs only what he deeply trusts—building governance-first AI that helps teams move faster without compromising patients, integrity, or compliance.
Compliance, complexity,
and the responsible use of AI
Compliance with the ABPI Code and associated UK and EU regulatory frameworks extends beyond checklist-based review. Reference accuracy, citation relevance, and contextual use of evidence are routinely examined by regulators and self-regulatory bodies.
At the same time, pharmaceutical organisations are under increasing pressure to adopt AI-enabled tools — often without clear guidance on how these technologies can be deployed in a compliant, defensible manner.
The challenge is not whether AI will be used, but how it can be introduced realistically, responsibly, and in a way that strengthens — rather than undermines — existing compliance frameworks.
Expert-designed workflows,
enabled by trusted AI
The platform applies AI within structured, regulator-informed workflows to support pharmaceutical compliance activities. AI is developed and governed by experienced data scientists, and applied in a way that enhances expert review — not replaces professional judgement.
The result is a system that organisations can adopt with confidence as part of a controlled and compliant AI transition.
DAAI Capabilities
Reference & Citation Checking
Verification of references against original source material
Identification of inconsistencies, omissions, and unsupported claims
Support for ABPI Code-aligned use of evidence
Compliance-Aligned Workflows
Designed around ABPI Code principles and enforcement realities
Adaptable for UK and EU regulatory contexts
Supports consistent application across teams and functions
Audit, Governance & AI Oversight
Clear, structured outputs with traceability to sources
Designed to support internal governance and regulatory scrutiny of AI-assisted processes
Outputs are structured to be reviewed, challenged, and defended.
Outputs are structured to be reviewed,
challenged, and defended.
Regulatory and AI
expertise at the core
The platform has been developed through close collaboration between senior pharmaceutical regulatory professionals and expert data scientists with deep experience in applied AI.
This combined expertise informs not only what the system does, but how AI is trained, governed, and constrained within compliance-critical workflows. The result is an approach that reflects both regulatory expectations and best practice in responsible AI development.
Regulatory insight and technical rigour are foundational to the platform's design and ongoing evolution.
What is DAAI Support?
Compliance Functions
Scale review capacity while maintaining regulatory control
Improve consistency and transparency across compliance activities
Introduce AI support without increasing regulatory exposure
Legal & Governance
Scale review capacity while maintaining regulatory control
Improve consistency and transparency across compliance activities
Introduce AI support without increasing regulatory exposure
Medical Affairs
Greater confidence in referenced scientific materials
Earlier support in content development and review cycles
Reduced rework and late-stage revision
Senior Leadership
Controlled adoption of AI
Reduced operational and regulatory risk
Confidence in organisational readiness for AI-enabled compliance
DAAI — UK and EU
Get in Touch
Whether you have a question, an idea, or just want to say hello, feel free to reach out—we're here to help.